Posts by: Patricia Inacio, PhD

In a recent Morbidity and Mortality Weekly Report from the Centers for Disease Control and Prevention (CDC), researchers show that deaths due to Alzheimer’s disease increased almost 55% between ... Read more

May 16, 2017May 16, 2017

Preventing Diabetes May Help Halt Alzheimer’s Progression in New York State, Report Says

News

The state of New York lacks effective measures for preventing diabetes, which is fueling a dramatic increase in Alzheimer’s disease. So says a new document, “Unprevented Diabetes Means Unnecessary Alzheimer’s,” issued by Health ... Read more

May 8, 2017

ALZ-801 Works Against Alzheimer’s by Preventing Protein Component Clumping, Study Reports

News

The Alzheimer’s therapy ALZ-801 works by preventing protein components from clumping together to trigger the amyloid plaque accumulation in the brain that causes the disease, researchers say. Disease-modifying drugs for Alzheimer’s ... Read more

May 3, 2017

‘Memory Protein’ NPTX2 Underlies Cognitive Decline in Alzheimer’s, Researchers Find

News

Memory loss and cognitive dysfunction, two hallmarks of Alzheimer’s disease, have now been linked to low levels of one particular protein, called NPTX2. The discovery represents a stepping-stone in ... Read more

March 14, 2017

Diabetes Therapy Symlin Could Lead to Faster Diagnostic Tests for Alzheimer’s

News

The diabetes drug Symlin (pramlintide) may help scientists develop novel and faster diagnostic tests for Alzheimer’s disease (AD), a study indicates. The research, “An amylin analog used as a ... Read more

March 2, 2017

Middle-Age Diabetes, High Blood Pressure, Smoking Boost Dementia Risk, Study Says

News

Factors known to increase risk for heart disease during middle age – diabetes, high blood pressure and smoking – also raise the risk of dementias such as Alzheimer’s disease later ... Read more

January 3, 2017January 3, 2017

Gene, Linked for 1st Time to Alzheimer’s, May Lead to Blood Test of Susceptibility

News

Researchers have identified a new gene, called Rgs2 (Regulator of Protein Signaling 2), whose expression levels may be used in future diagnostic blood tests for early detection of Alzheimer’s ... Read more

November 17, 2016November 17, 2016

Probiotics Trial in Alzheimer’s Patients Shows Promise in Improving Brain Function

News

Researchers from Iran show in the first human trial that probiotics appear to improve brain cognition in humans. The study, “Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status ... Read more

July 18, 2016July 20, 2016

Potential Alzheimer’s Vaccine Undergoing Pre-Clinical Trial Tests

News

Scientists have developed a novel form of vaccine targeting the two main proteins triggering Alzheimer’s disease, amyloid-beta and tau protein. Researchers and physicians have seen an increase in Alzheimer’s disease, with more ... Read more

July 5, 2016July 5, 2016

Alzheimer’s Therapy Candidate Bryostatin Generates New Synapses in Mouse Brains, Study Shows

News

Neurotrope Bioscience’s lead Alzheimer’s drug candidate, bryostatin, promotes the formation of new synapses in the brains of mice, according to the study, “PKC epsilon Promotes Synaptogenesis through Membrane accumulation of the ... Read more